share_log

天津发展(00882.HK):力生制药一季度净利润5915.56万元 同比增长27.22%

Tianjin Development (00882.HK): Lisheng Pharmaceuticals' net profit of 59,155,600 yuan in the first quarter increased 27.22% year-on-year

Gelonghui Finance ·  Apr 24 18:22

Gelonghui, April 25 | Tianjin Development (00882.HK) announced that in the first quarter of 2024, Lisheng Pharmaceutical (002393.SZ) achieved operating income of 365 million yuan, up 8.71% year on year; net profit attributable to shareholders of listed companies (Lisheng Pharmaceutical) was 59,1556 million yuan, up 27.22% year on year; net profit attributable to shareholders of listed companies (Lisheng Pharmaceuticals) after deducting non-recurring profit and loss was 58.7736 million yuan, up 29.71% year on year; basic earnings per share were 0.32 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment